68
Participants
Start Date
October 1, 2017
Primary Completion Date
February 22, 2023
Study Completion Date
February 22, 2023
Sertraline
Participants start at 12.5 mg and are increased by 12.5/day every two weeks for 14-16 weeks based on their tolerability to the medication. Dosing is capped at 125mg/day.
CBT/BIACA
Participants receive 16 weeks of BIACA therapy.
Placebo
Participants are given a placebo capsule with an administration schedule matching that of the sertraline subjects.
UC Davis MIND Institute, Sacramento
University of California, Davis
OTHER